Awards and Patents
Krishgen was proud to be recognised as one of India’s Top 10 Biotech Companies in 2023 by Pharma Outlook magazine. It represents a culmination of 20 years of service to the industry and our commitment to being ahead of the curve.
The CiteAb Innovation Award highlights an innovative product that has satisfied a gap in the market or solved a known issue within the respective field. Krishgen was Highly Commended in this category by CiteAb for the development of Bispecific ELISA, the first of its kind in the world. The bsAb ELISA are quantitative assays for detection of bispecific antibody drugs that are becoming popular therapeutic targets.
Neelam Jain, CEO and co-founder of Krishgen was awarded the Women Entrepreneur Of The Year award by The CEO Magazine in 2020, an award that celebrates revolutionary women entrepreneurs for remarkable contribution to their industry.
We are happy when our efforts are recognized by peers. Global Health and Pharma Magazine, UK awarded us the best drug discovery product manufactured for our development of Nipah Virus ELISA kit for 2019.
CBR No:31362 & Patent Application No:202021054933 in India Territory
Enzyme Immunoassay for Qualitative Determination of Atezolizumab Neutralizing Antibody in Human Serum, Plasma.
CBR No:31364 & Patent Application No:202021054935 in India Territory
Enzyme Immunoassay for Qualitative Estimation of Degarelix in Human Serum, Plasma and Cell Culture Supernatant.